San Diego, CA, United States of America

Natalie Anne Hawryluk

This inventor holds 24 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 6 EPO patents, primarily in Pharmaceutical Compounds. Top assignees: Janssen Pharmaceutica Nv, Celgene Corporation, Zoetis LLC. Active years: 2013-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Natalie Anne Hawryluk. Retrieved from https://idiyas.com/inventor/natalie-anne-hawryluk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 

% Patents Active = 62.5

 

 

Average Co-Inventor Count = 5.1

ph-index = 4

Forward Citations = 60(Granted Patents)


Company Filing History:


Years Active: 2013-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Heterocyclic Compounds
Anti-Malarial Agents
TRPV1 Modulators
Fatty Acid Hydrolase
Helminthic Infections
Anti-Trypanosomal
Anti-Leishmania
Flap Modulators
Tetrahydro-Pyrimidoazepines
Aryl-Substituted Urea
Heteroaryl-Substituted Urea
Fatty Acid Amide Hydrolase
24 patents (USPTO):Explore Patents

Title: Exploring the Innovations of Natalie Anne Hawryluk

Introduction

Natalie Anne Hawryluk is a prominent inventor based in San Diego, California, known for her significant contributions to the field of medicinal chemistry. With an impressive portfolio of 23 patents, she has dedicated her career to developing innovative solutions for treating various diseases.

Latest Patents

Among her latest patents are groundbreaking inventions focused on combating serious health issues. One notable patent involves heterocyclic compounds and their use for the treatment of helminthic infections and diseases. Another key patent is centered on animal and human anti-malarial agents, featuring Purine Compounds that aim to provide effective treatments against malaria. These patents highlight her commitment to advancing medical research and improving public health outcomes.

Career Highlights

Throughout her career, Natalie has worked with esteemed companies in the pharmaceutical industry, including Janssen Pharmaceutica and Celgene Corporation. Her experience in these organizations has allowed her to refine her expertise in drug development and innovation, contributing significantly to advancements in medicinal therapies.

Collaborations

Natalie has collaborated with notable professionals in her field, including John M. Keith and William Moore Jones. These partnerships have fostered a rich environment for innovation, enabling her to leverage diverse expertise in the development of her patented inventions.

Conclusion

In summary, Natalie Anne Hawryluk's work exemplifies the spirit of innovation in the pharmaceutical sector. Her 23 patents reflect her dedication to improving health outcomes through her research and development efforts. As a leading inventor, she continues to make strides in the fight against serious diseases, further establishing her legacy in the world of medical chemistry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…